Search research articles
Contact Us
Filters
Showing results (41-50 of 104) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy
Brian H Kushner, Samuel D J Yeh, Kim Kramer, et al.
Pediatric Blood & Cancer
|
June 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma
Wei Wei, Maggie Eidson Fader, Brian H Kushner, et al.
Cancer
|
May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody
Brian H Kushner, Shakeel Modak, Ellen M Basu, et al.
Cancer
|
September 7, 2012
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature
Brian H Kushner, Shakeel Modak, Kim Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2
Matthias Miederer, Michael R McDevitt, Paul Borchardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 12, 2010
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid
Ping He, Kim Kramer, Peter Smith-Jones, et al.
Journal of Neuro-Oncology
|
March 18, 2019
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes
Kayleen Bailey, Neeta Pandit-Taskar, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2023
Radioimmunoscintigraphy and Pretreatment Dosimetry of <sup>131</sup>I-Omburtamab for Planning Treatment of Leptomeningeal Disease
Neeta Pandit-Taskar, Milan Grkovski, Pat B Zanzonico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
Nai-Kong V Cheung, Irene Y Cheung, Brian H Kushner, et al.
Oncoimmunology
|
July 4, 2015
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub> immunotherapy and isotretinoin: a prospective Phase II study
Brian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 104) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy
Brian H Kushner, Samuel D J Yeh, Kim Kramer, et al.
Pediatric Blood & Cancer
|
June 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma
Wei Wei, Maggie Eidson Fader, Brian H Kushner, et al.
Cancer
|
May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody
Brian H Kushner, Shakeel Modak, Ellen M Basu, et al.
Cancer
|
September 7, 2012
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature
Brian H Kushner, Shakeel Modak, Kim Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2
Matthias Miederer, Michael R McDevitt, Paul Borchardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 12, 2010
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid
Ping He, Kim Kramer, Peter Smith-Jones, et al.
Journal of Neuro-Oncology
|
March 18, 2019
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes
Kayleen Bailey, Neeta Pandit-Taskar, John L Humm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 9, 2023
Radioimmunoscintigraphy and Pretreatment Dosimetry of <sup>131</sup>I-Omburtamab for Planning Treatment of Leptomeningeal Disease
Neeta Pandit-Taskar, Milan Grkovski, Pat B Zanzonico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
Nai-Kong V Cheung, Irene Y Cheung, Brian H Kushner, et al.
Oncoimmunology
|
July 4, 2015
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub> immunotherapy and isotretinoin: a prospective Phase II study
Brian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Page
of 11